247 related articles for article (PubMed ID: 38104042)
21. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
22. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator.
Karamanou K; Franchi M; Vynios D; Brézillon S
Semin Cancer Biol; 2020 May; 62():125-133. PubMed ID: 31401293
[TBL] [Abstract][Full Text] [Related]
24. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition.
Bong AHL; Monteith GR
Int J Biochem Cell Biol; 2017 Jun; 87():23-26. PubMed ID: 28336365
[TBL] [Abstract][Full Text] [Related]
26. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.
Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA
Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity.
Drasin DJ; Robin TP; Ford HL
Breast Cancer Res; 2011; 13(6):226. PubMed ID: 22078097
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Brown MS; Abdollahi B; Wilkins OM; Lu H; Chakraborty P; Ognjenovic NB; Muller KE; Jolly MK; Christensen BC; Hassanpour S; Pattabiraman DR
Sci Adv; 2022 Aug; 8(31):eabj8002. PubMed ID: 35921406
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.
Guha M; Srinivasan S; Ruthel G; Kashina AK; Carstens RP; Mendoza A; Khanna C; Van Winkle T; Avadhani NG
Oncogene; 2014 Nov; 33(45):5238-50. PubMed ID: 24186204
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
Hennessy BT; Gonzalez-Angulo AM; Stemke-Hale K; Gilcrease MZ; Krishnamurthy S; Lee JS; Fridlyand J; Sahin A; Agarwal R; Joy C; Liu W; Stivers D; Baggerly K; Carey M; Lluch A; Monteagudo C; He X; Weigman V; Fan C; Palazzo J; Hortobagyi GN; Nolden LK; Wang NJ; Valero V; Gray JW; Perou CM; Mills GB
Cancer Res; 2009 May; 69(10):4116-24. PubMed ID: 19435916
[TBL] [Abstract][Full Text] [Related]
31. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.
Ocaña OH; Córcoles R; Fabra A; Moreno-Bueno G; Acloque H; Vega S; Barrallo-Gimeno A; Cano A; Nieto MA
Cancer Cell; 2012 Dec; 22(6):709-24. PubMed ID: 23201163
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer.
Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC
Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755
[TBL] [Abstract][Full Text] [Related]
33. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
Sarrió D; Rodriguez-Pinilla SM; Hardisson D; Cano A; Moreno-Bueno G; Palacios J
Cancer Res; 2008 Feb; 68(4):989-97. PubMed ID: 18281472
[TBL] [Abstract][Full Text] [Related]
34. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
35. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
[TBL] [Abstract][Full Text] [Related]
36. Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.
Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Del Barco S; Martin-Castillo B; Menendez JA
Cell Cycle; 2010 Sep; 9(18):3807-14. PubMed ID: 20890129
[TBL] [Abstract][Full Text] [Related]
37. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
38. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
39. Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.
Leontovich AA; Zhang S; Quatraro C; Iankov I; Veroux PF; Gambino MW; Degnim A; McCubrey J; Ingle J; Galanis E; D'Assoro AB
Int J Oncol; 2012 Jun; 40(6):1858-64. PubMed ID: 22447278
[TBL] [Abstract][Full Text] [Related]
40. Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells.
Yang M; Ma B; Shao H; Clark AM; Wells A
BMC Cancer; 2016 Jul; 16():419. PubMed ID: 27387344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
